August 22, 2008 - The 23rd Annual Advances in Contrast Ultrasound: Atherosclerosis Imaging and Interventions/Bubble Course will explore applications of contrast ultrasound Sept. 18-19 at the Millennium Knickerbocker Hotel in Chicago.
August 22, 2008 - St. Jude Medical Inc. this week said the FDA approved of the company’s new facility in Arecibo, Puerto Rico, for the manufacturing of pacemakers and cardiac leads.
August 21, 2008 - CardioECG 3.2, introduced by LUMEDX Corp. and Epiphany Cardiography Products, is a multimodality ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 21, 2008 – The first U.S. patient implanted with the DuraHeart Left Ventricular Assist System (LVAS) was ...
August 20, 2008 — FiatLux Imaging Inc. — a high-tech company founded by former Microsoft software veterans — said the ...
Bracco's Isovue (iopamidol injection) X-ray/CT contrast is reportedly a safe and effective nonionic contrast agent, which is well established with U.S. clinical experience since 1986. Worldwide, more than 250 million doses of iopamidol have been administered, the company said.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 20, 2008 - Royal Philips Electronics said today it will lead a new European Union-funded research project called ...
August 20, 2008 - Diagnostic testing conducted at or near the site of the patient, known as patient-side point-of-care ...
August 19, 2008 - Dräger Medical Inc. today said its Fabius MRI anesthesia machine received FDA clearance, and is designed specifically to meet the requirements for the magnetic resonance imaging (MRI) environment.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 19, 2008 - FiatLux Imaging Inc. today released its FiatLux Visualize medical imaging application that capitalizes ...
St. Jude Medical Inc. received European CE Mark approval and FDA clearance for the Epicor LP Cardiac Ablation System, a second generation technology that uses HIFU (high intensity focused ultrasound) to surgically ablate cardiac tissue to disrupt abnormal electrical impulses in the heart.
August 18, 2008 - Atritech Inc. today said it filed its pre-market approval application (PMA) with the FDA for its WATCHMAN Left Atrial Appendage (LAA) Closure Technology, which contains the results of the PROTECT AF Clinical Trial which began enrollment in early 2005.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 19, 2008 – St. Jude Medical Inc. said today it received European CE Mark approval and FDA clearance for the ...
August 19, 2008 – Barco has released a new version of its Voxar 3D advanced visualization software suite that is ...
FiatLux Imaging Inc. offers its FiatLux Visualize medical imaging application that capitalizes on advanced video game ...